
Coronavirus News Roundup: Pharmacists Can Improve Vaccine Uptake; FDA and CDC Recommend Pause for Johnson & Johnson Vaccine
Here's a roundup of the latest coronavirus-related news.
As the United States nears the 200 million mark for the total number of COVID-19 vaccine doses administered, with 23.5% of Americans fully vaccinated against the virus as of April 15, coronavirus-related news is not slowing down.
Here’s a roundup of the latest coronavirus-related news, including a recent survey from the National Community Pharmacists Assocation (NCPA) and the CDC recommendation to temporarily pause the Johnson & Johnson vaccine.
According to a new survey from the National Community Pharmacists Association (NCPA), independent community pharmacists are key to vaccinating socially vulnerable populations, including minority populations, but many are receiving inadequate vaccine supply.
In a COVID-19 vaccine trial, an individual who received the vaccine subsequently developed Guillain-Barré syndrome; however, authors of a recently published paper are cautioning that this does not prove that the vaccine was the cause.
US health officials are recommending a pause in the administration of the single-dose Johnson & Johnson COVID-19 vaccine following 6 reports of a rare and severe type of blood clot, according to a joint statement issued on Tuesday by the CDC and FDA.
Although it is known that many patients hospitalized with COVID-19 report persistent long-term symptoms, there is not much knowledge regarding long-term outcomes among individuals with mild COVID-19.
What Contributes to Severe COVID-19 in Kids
COVID-19 may be mild in most cases for children, but severe cases do happen. An investigation offers insight into what factors may contribute to those cases.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.